Kyverna Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	53.44	96.62	34.65	37.74	76.07
Short-Term Investments	158.24	189.36	22.9	13.59	-
Cash & Short-Term Investments	211.68	285.98	57.54	51.32	76.07
Cash Growth	-42.76%	396.98%	12.12%	-32.53%	-
Prepaid Expenses	2.65	4.62	3.12	1.93	1.02
Total Current Assets	214.33	290.6	60.66	53.25	77.09
Property, Plant & Equipment	7.58	10.66	10.61	12.44	7.81
Long-Term Deferred Charges	-	-	2.5	-	-
Other Long-Term Assets	4.6	3.39	1.42	1.23	0.59
Total Assets	226.51	304.65	75.2	66.92	85.49
Accounts Payable	9.92	4.62	4.36	1.45	0.77
Accrued Expenses	26.3	11.13	9.06	7.66	7.77
Current Portion of Leases	3.58	3.94	2.92	2.28	0.81
Current Unearned Revenue	-	-	-	-	6
Other Current Liabilities	-	14.06	3.52	0.57	0.58
Total Current Liabilities	39.79	33.76	19.86	11.95	15.93
Long-Term Leases	2.34	4.3	6.16	8.29	4.74
Long-Term Unearned Revenue	-	-	-	-	1.03
Other Long-Term Liabilities	-	-	-	0.01	1.33
Total Liabilities	42.13	38.06	26.02	20.25	23.02
Additional Paid-In Capital	534.63	530	4.64	1.71	0.53
Retained Earnings	-350.24	-263.52	-136.04	-75.68	-46.78
Comprehensive Income & Other	-0.02	0.11	0	-0.03	-
Total Common Equity	184.38	266.59	-131.4	-74	-46.25
Shareholders' Equity	184.38	266.59	49.18	46.68	62.47
Total Liabilities & Equity	226.51	304.65	75.2	66.92	85.49
Total Debt	5.92	8.24	9.08	10.56	5.56
Net Cash (Debt)	205.76	277.74	48.46	40.76	70.51
Net Cash Growth	-42.68%	473.08%	18.91%	-42.20%	-
Net Cash Per Share	4.76	7.25	71.95	89.48	265.19
Filing Date Shares Outstanding	43.24	43.21	43.12	0.55	0.27
Total Common Shares Outstanding	43.24	43.21	1.25	0.55	0.27
Working Capital	174.54	256.85	40.81	41.3	61.16
Book Value Per Share	4.26	6.17	-105.11	-133.91	-173.96
Tangible Book Value	184.38	266.59	-131.4	-74	-46.25
Tangible Book Value Per Share	4.26	6.17	-105.11	-133.91	-173.96
Machinery	-	6.2	4.17	3.74	3.35
Leasehold Improvements	-	0.82	0.65	0.46	0.08

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q